Chinese researchers find way to ease radiotherapy caused pain

 Chinese researchers have found that the medication pregabalin can help alleviate cancer     patients’ neuropathic pain caused by radiotherapy.

Chinese researchers find way to ease radiotherapy caused pain

Although radiotherapy can increase the survival rate of patients with head and neck cancer and prolong the survival period, many of these patients suffer from the severe complications.

interesting reading:  Breakthrough Towards Lasers Powerful Enough to Investigate a New Kind of Physics

Neuropathic pain after therapy severely affects patients’ daily lives and may even lead to emotional disorders such as anxiety and depression.

Conventional painkillers have poor effects on neuropathic pain caused by radiotherapy and there are no randomized clinical trials in this direction in the world.

Researchers from Sun Yat-sen University conducted a randomized controlled trial to test the efficacy and safety of pregabalin in the treatment of radiotherapy-related neuropathic pain.

interesting reading:  Chinese Researchers Develop Blood Test For Cancer Early Detection Upto Four Year

The clinical trial started in 2013, and 128 patients treated with radiotherapy for head and neck cancer from four medical centers around China were enrolled for the program.

Results showed that after 16 weeks of treatment, the pain index of the patients is reduced by 37 percent. At the same time, it can help alleviate negative emotions caused by pain.

The research was published in the Journal of Clinical Oncology.

interesting reading:  Chinese Researchers By Using Bioprinting Treats Gastric Wounds

Professor Tang Yamei, the leading researcher, has been treating radiation-induced brain injuries for 18 years at a hospital affiliated with the university.

“I have witnessed many cancer survivors who suffered from chronic pain after therapy-treatment. It is quite necessary to find safe and effective analgesic treatment for these patients,” Tang said.

READ MORE :

Leave a Reply

Your email address will not be published. Required fields are marked *

Captcha loading...